Symposium on Personalized Medicine
Auditorium Technopark Zurich, Technoparkstrasse 1, Zurich
Humans differ not only in their appearance but also in their responses to medication and the susceptibility to diseases. These differences are determined to a large extent by our genome that is stored in our cells in the form of DNA. The deciphering of the human genome sequence cost 3 billion Swiss Francs 10 years ago. Owing to dramatic technical progress in DNA sequencing the determination of the genome sequence of individual persons will soon cost less than 1'000 Swiss Francs. This will permit individuals to learn more about themselves and their ancestry. By providing their anonymized genome sequence, health and medical records to medical research they can make an active contribution the understanding and treatment of diseases. Over the past 10 years we have learnt that only the comparison of millions of such datasets will permit physicians to make more reliable diagnoses and recommendation for disease prevention. As we deposit our money safely in the bank and expect interests, we may in the near future deposit our genome sequence and medical records to obtain personalized health recommendations and medical treatment. The opportunities and the challenges associated with the availability of personal genome data will be discussed at the Symposium "Personalized Medicine" that is organized by Life Science Zurich Business Network on September 13, 2011 at Technopark Zurich.
The association "Life Science Zurich Business Network" has been founded in 2011 and is the Zurich HealthTIES partner. The symposium on personalized medicine is the launch symposium of this association. Registration is free. Please visit the Life Science Business Network website: http://www.lifescience-businessnetwork.ch
